Greytown Advisors’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$1.9M Buy
2024
Q1
$2.19M Sell
2023
Q4
$2.1M Buy
2023
Q3
$2.02M Buy
2023
Q2
$2.13M Buy
2023
Q1
$2.47M Buy
2022
Q4
$2.16M Buy
2022
Q3
$2.03M Sell
2022
Q2
$5.61M Buy
2022
Q1
$5.11M Buy
2021
Q4
$5.06M Buy
2021
Q3
$3.84M Buy